PHT Corporation, the market-leading provider of electronic patient reported outcome (ePRO) solutions used in more than 360 clinical trials worldwide, is providing its innovative LogPad® System to help headache experts at Clinvest Clinical Research measure cognitive deficits during migraine attacks in a sponsored clinical trial. This is the first time cognitive processing time has been tested in a major migraine research study.

A new University of Cincinnati ( UC ) master’s degree program will offer practicing physicians comprehensive training in clinical research. The goal is to train more physicians who can lead independent clinical research projects.

This video is to help answer some questions u may have about clinical research.

You are cordially invited to attend the complimentary workshop "Successful Clinical Trial Management: Challenges and Solutions", arranged by Covance. A panel of local industry and Covance speakers will discuss key challenges you face on an everyday basis and how to resolve them, including:

- Effective Management of Risk: Cost, Benefits and Adaptation
- Proactively Identifying the Best Sites and Predicting Resource Requirements
- Ensuring Compliance in Global Trials: A Regulatory Perspective
- Handle with Care: Improve Data Quality without Introducing Bias continue reading

A pharma industry partnering event with industry delegates from all over the world.

Historically, this partnering event delivers an average of more than 23 pre-scheduled appointments per participating company for Collaborative Agreements in Generics (incl. Bio-generics and Biosimilars), OTC Drugs, and Nutraceuticals - Development, Licensing, Marketing and Distribution.
continue reading

Prospects for Repurposing
How to Reposition Drugs
Case Histories

SPICA 2008 is the 12th event in a series of symposia started in Paris in 1986. This has become over the past years a regular appointment for scientists and practitioners involved in the downstream processing of fine chemicals, natural products, drugs, food activities, flavors and aromas.
continue reading

For more information visit: http://www.asn-online.org/education_and_meetings/renal_week/

A clinical study is under way to test the effectiveness of an investigational drug in reducing heart and kidney health problems in type 2 diabetics.

The Oklahoma Medical Research Foundation is adding a new research program focusing on studying and treating patients with autoimmune disorders including multiple sclerosis, lupus, and rheumatoid arthritis.

The Clinical Immunology Research Program will be headed by Judith James. The new program is part of a larger initiative at OMRF to increase translational research - work that focuses on transforming discoveries in the laboratory into new diagnostics and treatment for human disease.
continue reading

A new experimental medication that may increase a tumor's sensitivity to the most commonly prescribed ovarian cancer chemotherapy is now being tested at Scottsdale Healthcare.

continue reading

In the fast-paced world of emergency medicine, doctors and paramedic first responders must solve problems fast and efficaciously.

This critical time frame is especially important when a patient exhibits neurological damage and is having seizures.

UCSF’s Claude Hemphill, MD, director of the Neurocritical Care Program at San Francisco General Hospital (SFGH), is leading a team for the San Francisco portion of a national study to determine the best treatment for a prolonged seizure called status epilepticus.

continue reading

Synageva BioPharma announced today the appointment of Sanj K. Patel as President and Chief Executive Officer. Sanj joins Synageva from Genzyme Therapeutics and brings experience from one of the industry's leading biopharmaceutical producers and an extensive background in directing successful clinical development and marketing programs as well as overseeing commercial operations.

continue reading